Introduction
============

Understanding the molecular underpinnings that produce physiological, cognitive, and morphological differences between organisms is a major challenge for biologists. Using forward genetics approaches, scientists have begun to establish direct connections between lineage-specific traits and molecular evolution. For example, to achieve complete ventricular septation, which allows for separation of oxygenated and deoxygenated blood, developing mammalian hearts express the transcription factor *Tbx5* in a pattern distinct from their ancestors ([@msv344-B24]). Furthermore, in stickleback fish, loss of a single tissue-specific enhancer of the *Pitx1* gene causes loss of pelvic spines ([@msv344-B12]). In flies, nucleotide changes in multiple enhancers for *shavenbaby* lead to species-specific trichome patterns ([@msv344-B28]; [@msv344-B16]). However, an approach that surveys large portions of the genome is required to gain a more comprehensive view of how molecular evolution relates to lineage-specific traits. One such approach is comparative genomics, which allows for scanning of entire genomes for DNA sequences that have a key evolutionary signature: Differences in nucleotides suggesting that these sequences are responsible for making one species different from another. A scanning technique to identify conserved genome sequences with many changes in one extant lineage was first developed to discover human accelerated regions (HARs) ([@msv344-B35]; [@msv344-B37]; [@msv344-B24]) and has been used to identify genomic regions with elevated substitution rates in many other lineages ([@msv344-B12]; [@msv344-B25]). Others have identified lineage-specific conserved noncoding elements within a group that are either deposited by mobile elements ([@msv344-B4]; [@msv344-B26]; [@msv344-B41]) or are otherwise absent in other groups ([@msv344-B29]). We extend this framework for testing conservation and acceleration on terminal branches to enable identification of changes in the rate of molecular evolution on an ancestral lineage. Specifically, we identify both coding and noncoding sequences over the entire genome that are present in vertebrates, evolved rapidly in the ancestral lineage of therian mammals but are then conserved in its descendants. Such a pattern suggests that the ancestors experienced a change in function, and the change in sequence was then constrained in descendants to maintain this new function.

We tested the branch leading to therian mammals to understand the genetic basis for differences in morphology and physiology from other vertebrates ([fig. 1*A*](#msv344-F1){ref-type="fig"}). Therian mammals consist of marsupials (e.g., wallaby, opossum) and eutherians (e.g., human, dog) to the exclusion of the third group of extant mammals---the monotremes (e.g., platypus, echidna). Therians diverged from monotremes ∼190 Ma ([@msv344-B27]). Therians are diverse and widespread, and they share several unique traits that distinguish them from other vertebrates, such as having live young, a regular heartbeat, a higher and possibly more constant body temperature, a higher metabolic rate, erect limb posture, and true nipples. Conversely, monotremes retained many traits present in the earliest mammals, some of which are shared with extant reptiles, including the cloaca (a single opening for urinary, defecatory, and reproductive functions), a sprawling gait, an uncoiled cochlea in the inner ear, lack of or reduced sweat glands, and egg laying ([@msv344-B39]; [@msv344-B52]; [@msv344-B47]; [@msv344-B50]; [@msv344-B6]; [@msv344-B2]). Thus, therians are distinct from monotremes and other vertebrates in their morphology and physiology. We set out to discover the genetic basis for therian-specific traits. F[ig]{.smallcaps}. 1.(*A*) Phylogenetic tree of vertebrates used to identify TSARs; internal test for acceleration was conducted on the red branch, which unites therians. (*B*) TSARs and TCRs are distributed among genomic features in similar proportions with slightly more exonic and less intronic sequence in TSARs.

Results and Discussion
======================

Comparative Genomics Identifies Hundreds of Sequences That Distinguish Therian Mammals from Other Vertebrates
-------------------------------------------------------------------------------------------------------------

We used phyloP combined with the phastCons program in PHAST ([@msv344-B34]; [@msv344-B23]) to scan whole-genome alignments in vertebrates for sequences that are present in therian and nontherian vertebrates but changed significantly in the therian mammal ancestor and remained highly conserved during therian diversification. We identified 177,346 vertebrate genomic regions that are conserved among therians (therian conserved regions; TCRs), of which 4,797 have a strong signature for accelerated evolution in the therian ancestor (false discovery rate \<1%; [supplementary table S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). We call these 4,797 sequences Therian-Specific Accelerated Regions (TSARs). Using simulations (see Materials and Methods), we established that the power of this method is sufficient to identify TSARs and that specificity is high for elements over 150 bp. For longer elements, power and specificity are remarkably high (supplementary fig. S1*C*, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online).

The distribution of TSARs with respect to human gene features is similar to that of TCRs ([fig. 1*B*](#msv344-F1){ref-type="fig"}). TSARs are largely within genic regions ([supplementary table S2](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online), in contrast to HARs and the mammalian-conserved elements from which HARs were identified, both of which occur most frequently in intergenic DNA ([@msv344-B35]; [@msv344-B25]). This distribution difference may be because intergenic sequences typically evolve more rapidly and are therefore more difficult to align in the TSAR analysis, which adds a requirement of syntenic alignment to nonmammalian vertebrates (see Materials and Methods).

To explore the hypothesis that TSARs are uncharacterized regulatory elements, we used functional genomics data from the ENCODE project ([@msv344-B14]) and other sources ([@msv344-B19]; [@msv344-B45]; [@msv344-B9]; [@msv344-B38]; [@msv344-B42]) to investigate how many TSARs overlap features indicative of enhancer or promoter activity in various human and mouse cell types ([supplementary table S1](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). We found widespread evidence that TSARs are active regulatory sequences. First, from human ENCODE data, 89% of TSARs overlap with DNaseI hypersensitive sites, H3K27 acetylation marks, or P300 peaks, all of which indicate regulatory activity. Furthermore, the chromHMM analysis of human ENCODE data ([@msv344-B15]) predicts that 14% of TSARs are promoters and 35% are enhancers, and only 12.7% of TSARs are in intergenic regions without any predicted regulatory function. Furthermore, 98% of TSARs that overlap chromHMM-predicted enhancer sequences are supported by at least one additional experiment showing evidence of enhancer activity, and 89% are supported by multiple additional experiments. These include 366 TSARs that overlap elements from experiments designed to identify *cis*-regulatory regions in murine tissues ([@msv344-B42]), and 129 in putative regulatory regions in the Open Regulatory Annotation database ([@msv344-B19]).

A small number of TSARs have been characterized experimentally in previous studies. TSARs overlap 17 early developmental enhancers in humans ([@msv344-B38]) and 105 putative heart enhancers in mouse ([@msv344-B9]). Transgenic enhancer assays from the VISTA Enhancer Browser ([@msv344-B46]) show that 51 TSARs have enhancer activity in e11.5 mouse. These enhancers are primarily active in the brain, eye, nose, and limbs ([@msv344-B46]). Overall, 4,285 of the 4,797 TSARs display evidence of regulatory function, yet they are largely uncharacterized. Future studies of these loci may offer clues about therian-specific biology.

Mutations in TSARs Alter Protein Sequences
------------------------------------------

More than half of the TSAR sequences overlap exonic regions of the human genome. Therefore, we explored mechanisms of evolution and the putative functional consequences of substitutions in the protein-coding regions of TSARs. Rapid evolution in protein-coding regions could be due to selection on protein function, rates of protein synthesis, or DNA- or RNA-binding elements. Using only the coding portions, we estimated rates of nonsynonymous (dN; amino acid altering) and synonymous (dS; non--amino acid altering) substitutions using Phylogenetic Analysis by Maximum Likelihood ([@msv344-B55]) on the mammal ancestor and on the therian ancestor branches. Our analysis is conservative in that we required sequence to be present in both marsupials, the monotreme and at least one eutherian and one nonmammalian vertebrate. Median estimates of these substitution rates indicate that protein-coding TSARs evolved rapidly at synonymous sites and only slightly higher at nonsynonymous sites in the therian ancestor compared with the mammal ancestor ([supplementary table S3](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). However, some TSAR-containing genes have high rates of nonsynonymous substitution compared with synonymous substitution on the therian ancestor branch, which may indicate adaptive protein evolution ([fig. 2*A*](#msv344-F2){ref-type="fig"}). These genes are involved in diverse yet vital functions that include spermatogenesis and neural development and many are either secreted or transmembrane proteins. Mutations in these genes are associated with cardiovascular disease, anhidrosis, skeletal abnormalities, hearing loss, and neurological diseases. Nonsynonymous substitutions in these genes had the potential to alter therian-specific traits. F[ig]{.smallcaps}. 2.(*A*) Thirteen human genes containing TSARs with nonsynonymous substitution rates (dN) at least 5× higher than the median and synonymous substitution rates (dS) less than half the median rate. This pattern may indicate adaptive protein evolution resulting in altered functions. (*B*) Clusters of three or more TSARs, where neighboring TSARs ≤50 kb apart are found in 383 genomic loci. For the densest clusters, the nearest genes are labeled. Clusters primarily composed of coding sequence are in blue (\>75% dark blue; \>50% blue); predominantly noncoding sequence clusters are in red (\<50% coding sequence, red; \<25% coding sequence, dark red).

TSARs Cluster in Loci Associated with Disease and Development
-------------------------------------------------------------

In the genome, TSARs are significantly closer to one another than are TCRs (supplementary fig. S2, Supplemental Material online). We defined a "cluster" of TSARs as any set of three or more TSARs where the neighboring TSARs are ≤50 kb apart. We then associated these clusters with nearby genes. We speculated that TSAR clusters might pinpoint genes whose functions were hotspots of modification in the therian ancestor, either via regulatory divergence or through structural changes to the encoded protein. Genes harboring clusters of TSARs were more often associated with urogenital defects and to a lesser extent brain development than genes near or containing a single TSAR. The largest cluster (*n* = 36) centers on the developmental transcription factor, *Pax2*, which is active in the development of the mid-hindbrain boundary, the retina, the renal system, and the inner ear.

Previous studies have suggested that distinct sets of genes undergo either protein-coding or regulatory evolution ([@msv344-B54]). Consistent with this idea, we found that many TSAR clusters were either predominantly coding (\>75% coding sequence) or noncoding (\<25% coding sequence), with less than 30% of clusters having equal proportions of coding and noncoding sequence ([fig. 2*B*](#msv344-F2){ref-type="fig"} and [supplementary table S4](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). Interestingly, we found further distinguishing characteristics within coding clusters---specifically that many protein-coding TSAR clusters (e.g., those in genes that encode UBE4A, DNAH2, HEATR1, SUPT16H, and WDFY3) are evolving rapidly at synonymous sites, which might indicate changes in translational efficiency and expression ([@msv344-B49]; [@msv344-B30]) or regulatory elements overlapping exons ([@msv344-B7]). Very few protein-coding TSAR clusters have high rates of nonsynonymous substitution ([fig. 2*A*](#msv344-F2){ref-type="fig"}) (supplementary fig. S3*A*, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). Taken together, the protein-coding TSAR clusters were not enriched for any particular biological processes. In comparison, as with clusters of TSARs in general, genes near or containing hotspots of noncoding TSARs are enriched for involvement in development of many brain regions and regulation of transcription. Because many TSARs that are clustered in these loci likely function as developmental enhancers or other modulators of expression, our results suggest that regulatory changes in the therian ancestor may have influenced neurodevelopment.

Multiple TSARs in the *Lhx1* Locus Function as Developmental Enhancers
----------------------------------------------------------------------

One large cluster of TSARs (*n* = 20) resides primarily in the intergenic region between *Lhx1*, a LIM-homeodomain transcription factor, and *Mrm1*, a mitochondrial rRNA methyl transferase (supplementary fig. S3*B*, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). These TSARs are largely uncharacterized---only three overlap validated enhancers: TSAR.0067:OREG0042899 ([@msv344-B51]), human ESC expression ([@msv344-B38]); TSAR.1565, expression in embryonic day 11.5 (e11.5) mouse limb ([@msv344-B46]); and TSAR.1586, expression in e14.5 brain ([@msv344-B42]). Using ENCODE data, chromHMM ([@msv344-B15]) predicted that eight others are also enhancers. Although both *Lhx1* and *Mrm1* are widely expressed, the LIM-homeodomain transcription factors are important for mammal-specific forebrain development and many of them are expressed together in specific subregions ([@msv344-B1]). To investigate if uncharacterized noncoding TSARs are novel enhancers of *Lhx1*, we used a transient transgenic reporter assay ([@msv344-B31]). In this assay, we determined if the mouse sequences of TSAR.0067 and TSAR.1586 show enhancer activity in e11.5 mouse embryos. We found that both TSARs drove reporter gene expression. TSAR.1586 produced a reproducible pattern of expression in the majority of embryos ([fig. 3](#msv344-F3){ref-type="fig"} and supplementary fig. S4 and table S5, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online), but TSAR.0067 was expressed in many embryos, yet showed a variable expression pattern between embryos (supplementary fig. S4 and table S5, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). This may be the result of testing at e11.5, because this enhancer is known to be active at earlier stages (e.g., human embryonic stem cells; [@msv344-B38]). TSAR.1586 was active in a small domain spanning the hypothalamus and telencephalon ([fig. 3](#msv344-F3){ref-type="fig"} and supplementary fig. S4, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). Hypothalamic expression was probably in the anlage of the paraventricular nucleus and with expression continuing into the telencephalic stalk and extending into the anlage of the amygdala, resembling the pattern of *Otp* expression ([@msv344-B3]; [@msv344-B18]). We repeated the transient transgenic experiment after replacing the mouse TSAR.1586 sequence with the orthologous chicken sequence (nontherian). This allowed us to test if changing this sequence in the therian ancestor altered the function of the *Lhx1* enhancer. The construct with the chicken TSAR.1586 sequence did not show reporter gene expression in the hypothalamus and telencephalon. Interestingly, therian-specific hypothalamic expression occurred in the paraventricular neurons, which project into the pituitary gland where they release oxytocin or vasopressin into circulation ([@msv344-B44]). Interestingly, oxytocin is involved in uterine contractions and milk ejection ([@msv344-B13]), whereas vasopressin regulates blood pressure ([@msv344-B40]) and temperature ([@msv344-B33]), all of which are critical features of therian-specific evolution. Further experimentation would be required to substantiate connection between this enhancer and regulation of hormones. F[ig]{.smallcaps}. 3.Enhancer activity of TSAR.1586. (*A* and *D*) LacZ-stained and (*B*, *C*, *E*, *F*) reconstructed three-dimensional image from optical projection tomography (OPT) of e11.5 mouse embryos show the enhancer activity of TSAR.1622 for (*A*--*C*, *E*, *F*) the mouse sequence and (*D*) the orthologous chicken sequence. (*C*) Rostral view of reconstructed OPT shows expression in the hypothalamus and telencephalon for the mouse construct. (*E* and *F*) Coronal sections from the mouse construct show specific expression along the telencephalic stalk into (*E*) the anlage of the amygdala and (*F*) the anlage of the paraventricular nucleus. pvn: paraventricular nucleus; a: amygdala.

Evolution of *Gata2* Enhancers May Be Important for Processing Visual Information
---------------------------------------------------------------------------------

*Gata2*, a well-characterized developmental transcription factor, functions during hematopoietic, central nervous system (CNS), and urogenital development in the mouse and chicken, all of which are highlighted in the ontology overrepresentation analysis. A group of eight TSARs is located within the known regulatory boundaries of the developmental transcription factor *Gata2* (seven shown in supplementary fig. S3*C*, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online) ([@msv344-B56]; [@msv344-B10]). Of the eight, six are predicted to be enhancers (chromHMM) or are validated *Gata2* enhancers (TSAR.0153:OREG0002950 and TSAR.3936:OREG0002949) ([@msv344-B48]). TSAR.3936 also has enhancer activity in e11.5 heart ([@msv344-B45]). Using our transient transgenic reporter assay ([@msv344-B31]), we tested whether three uncharacterized noncoding TSARs---TSAR.1137, TSAR.1622, and TSAR.2014---are novel enhancers of *Gata2*. At e11.5, all three sequences drove expression in one or more tissues ([fig. 4](#msv344-F4){ref-type="fig"} and supplementary fig. S5 and table S5, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). As a positive control, we also tested TSAR.0153 and confirmed activity in embryonic vasculature ([@msv344-B48]). F[ig]{.smallcaps}. 4.Enhancer activity of TSAR.1622. (*A* and *E*) Endogenous *Gata2* expression by in situ hybridization in (*A*) e11.5 mouse and (*E*) stage HH25 chicken. (*B* and *F*) LacZ-stained e11.5 mouse embryos show enhancer activity of TSAR.1622 for (*B*) the mouse sequence construct and (*F*) the orthologous chicken sequence construct. Both overlap expression of *Gata2*. (*C*--*D*, *G*--*H*) Lateral and dorsal views of OPT in transgenic mice. (*B*--*D*) The mouse TSAR.1622 sequence shows strong expression in the spinal cord and mantle zone along a longitudinal band in an intermediate dorsal/ventral position of the midbrain, terminating in the pretectum, whereas (*F*--*H*) the chicken sequence does not show expression in the pretectum with (*G*) autofluorescence of the blood in the heart. pt: pretectum; cn: facial nerve; mb: midbrain; hb: hindbrain; sc: spinal cord.

The mouse version of TSAR.1622 showed strong enhancer activity in the CNS that recapitulated endogenous *Gata2* expression ([fig. 4](#msv344-F4){ref-type="fig"} and supplementary fig. S5 and table S5, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). Specifically, this enhancer was active at the midbrain/hindbrain patterning center (isthmus) and extended rostrally in the mantle zone along a longitudinal band in an intermediate dorsal/ventral position of the midbrain and caudal forebrain, terminating in the region of the pretectum (the latter regions also had extensive alar plate \[dorsal\] expression). In addition, activity in the hindbrain and spinal cord was robust along a ventral longitudinal domain that may include regions that produce motor neurons. Upon testing expression of the orthologous chicken TSAR.1622 sequence, we observed reporter gene expression in the spinal cord, similar to observations with the mouse version. Strikingly, the orthologous chicken sequence lacked reporter gene expression in the pretectum of the midbrain ([fig. 4](#msv344-F4){ref-type="fig"}), which is involved in processing visual information and mediating subconscious responses to light, the perception of pain, and REM (rapid eye movement) sleep. Thus, our discovery of a therian-specific enhancer of *Gata2* in the pretectum is particularly interesting because, early in their evolution, mammals exploited nocturnal niches, and this TSAR may be associated with vision ([@msv344-B20]).

*Gata2* also has an important role in regulating expression in the superior colliculus (SC), which mediates responses to visual inputs and is the primary integrating center for eye movements ([@msv344-B53]). Two known enhancers of *Gata2* drive expression in the SC, OREG0002948, which is highly conserved in amniotes, and OREG0002951, which has no similar sequence in nonmammalian vertebrates. In the SC of mice, OREG0002948 alone can regulate *Gata2* ([@msv344-B32]). The orthologous OREG002948 sequences in the human and chicken have only 10% sequence divergence, which may indicate that the chicken sequence is also an enhancer of *Gata2* in the SC. The pretectum and SC are both critical for processing visual information, so the evolution of enhancers that modulate *Gata2* expression may indicate that this gene is important in therian-specific visual evolution.

TSARs Enhance Nearby Candidate Genes for Therian Traits
-------------------------------------------------------

Beyond TSARs within clusters, we also tested three other TSARs for enhancer activity based on their association with genes whose functions might be important in therian evolution. For all three, we confirmed enhancer function and observed significant differences in enhancer activity between the mouse and chicken sequences.

We chose to study TSAR.4350 ([@msv344-B19]) because therians differ in skeletal morphology from monotremes and TSAR.4350 has been shown to have enhancer activity in the developing limb ([@msv344-B9]). The expression patterns of reporter constructs with mouse and chicken TSAR.4350 sequences are extremely reproducible within each species, yet show dramatically different patterns between species ([fig. 5](#msv344-F5){ref-type="fig"} and supplementary fig. S6 and table S5, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). Both mouse and chicken TSAR.4350 sequences show expression in developing limbs, but the major differences are in the brain and CNS. Only the mouse enhancer produces reporter gene expression in the rhombic lip, rhombomeres 3--6, the tela chorioidea, and the medial pallium. Expression is also present in the roof plate epithelium in regions that are BMP+ and WNT+, yet it is absent in regions that would be FGF repressed ([@msv344-B43]). Expression picks up in the roof plate epithelium of the midbrain and pretectum, stopping at the pineal gland. Conversely, the chicken version of the enhancer is repressed anteriorly with expression in the roof plate epithelium starting at the cervical/thoracic junction. TSAR.4350 is in an intergenic region on chromosome 5 between *Npr3* and *Tars*. Although it is difficult to predict which gene TSAR.4350 is enhancing, expression patterns fit with those of NPR3 (or NPR-C), which is responsible for clearing natriuretic peptides, which regulate blood volume and pressure, in cerebrospinal fluid and other fluids ([@msv344-B36]). Also, the medial pallium, where TSAR.4350 is expressed, gives rise to the choroid plexus, which produces cerebrospinal fluid. Future experiments could test whether this sequence might have induced mammal-specific changes in how sodium levels are regulated in cerebrospinal fluid with respect to cerebral blood flow or pressure. F[ig]{.smallcaps}. 5.Enhancer activity of TSAR.3328. (*A* and *D*) LacZ-stained e11.5 mouse embryo expression of enhancer TSAR.3328 for (*A*) the mouse sequence construct and (*D*) the orthologous chicken sequence construct. (*B* and *C*) Lateral and rostral view of reconstructed OPT shows expression patterns for the mouse construct. Both (*A*--*C*) mouse and (*D*) chicken versions are expressed in the ventrolateral pallium, prethalamus, hindbrain, and spinal cord. (*A*--*C*) Mouse-specific expression is in the pretectum and caudomedial pallium. (*E* and *F*) Coronal sections from the mouse construct show specific expression in (*E*) the caudomedial pallium and (*F*) pretectum. pt: pretectum; pTh: prethalamus; vlp: ventrolateral pallium; cmp: caudomedial pallium.

Finally, we investigated two TSARs located in a gene-dense region on human chromosome 10*.* In the previous work, TSAR.3328 had enhancer activity in the developing forebrain ([@msv344-B9]), which is consistent with the complex pattern of activity we saw in the forebrain ([fig. 6](#msv344-F6){ref-type="fig"} and supplementary fig. S7 and table S5, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online): In the telencephalon, a longitudinal domain mapped to the progenitor zone of the ventrolateral pallium. Mantle zone activity was also found in the caudomedial pallium; this domain showed activity in continuity with the eminentia thalami, prethalamus, and possibly the paraventricular hypothalamus. The spinal cord had a longitudinal domain in an intermediate dorsoventral position. A separate domain was present as highly localized expression to a small region of the pretectum; this domain was specific to the mouse construct and completely absent in embryos with the chicken ortholog of the enhancer. For TSAR.0862, which has been identified as a putative liver enhancer in mouse (OREG0036240, [@msv344-B19]), the mouse construct caused consistent expression of the reporter gene in the epidermis and inconsistent activity in the brain, while the chicken construct produced variable patterns of expression in many embryos (supplementary fig. S7 and table S5, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). Both TSAR.3328 and TSAR.0862 enhancers lie within different introns of *Adk* (adenosine kinase) but are closer to the transcription start site of *Kat6b*, a histone acetyltransferase expressed during brain development ([@msv344-B11]). These TSARs are also within 500 kb of the *Ap3m1*, *Dupd1*, *Dusp13*, and *Samd8* transcription start sites. Further characterization of these TSARs would be necessary to determine which genes are targeted. F[ig]{.smallcaps}. 6.Enhancer activity of TSAR.4350. (*A*--*F*) LacZ-stained e11.5 mouse embryos show enhancer activity for (*A*--*C*) the mouse construct and (*D*--*F*) the chicken construct. (*B* and *E*) Caudal view showing mouse-specific expression in (*B*) the tela chorioidea, rhombic lip, and dorsal roof plate for the mouse version and (*E*) the roof plate posterior to the cervical/thoracic junction in the orthologous chicken version. (*C* and *F*) Rostral view showing expression in the medial pallium and dorsal roof plate to the pineal gland are specific to the (*C*) mouse construct and, showing expression in the posterior roof plate for both (*F*) chicken and (*C*) mouse constructs. mp: medial pallium; rp: roof plate; tc: tela chorioidea; rl: rhombic lip.

Conclusions
===========

Comparative genomics provides and approach to pinpoint the changes in coding and noncoding elements that result in the morphological and physiological differences that make us mammals. Our analysis of TSARs identified clusters of uncharacterized enhancers and proteins that are likely critical for the evolution of therian-specific traits. Of the TSARs, ∼90% show some evidence of regulatory function. These findings support the hypothesis that TSARs are signposts for shifts in function in the therian ancestor. Although we anticipated identifying elements that may have helped maintain a higher metabolic rate, a more constant body temperature, and an erect limb posture, our set of TSARs may target some of these physiological and morphological features, but predominately indicate alterations in the development of the CNS and the sensory and urogenital systems. Thus, comparative genomics approaches (such as the internal branch test) are extremely useful for discovering both expected and unexpected loci. This work brings us a step closer to unraveling the molecular mechanisms that underlie unique aspects of our biology. Now, the key is to develop high-throughput methods for ascertaining the functional impact of elements like HARs and TSARs and to discover how they relate to our unique biology.

Materials and Methods
=====================

Comparative Genomics Methods
----------------------------

### Genomic Sequence Data

The comparative genomic data we used were derived from the University of California--San Cruz (UCSC) 46-way multiple alignment files ([@msv344-B8]) that use hg19 as the reference genome. We used five high-quality genomes as representatives of eutherian mammals. Those species include human (hg19), mouse (mm9), cow (bosTau4), dog (canFam2), and elephant (loxAfr3). We also included sequences from two marsupials---opossum (monDom5) and wallaby (macEug1)---and a monotreme---the duck-billed platypus (ornAna1)---which all have complete genome sequences. The data set includes three members of the reptilian lineage---chicken (galGal3), zebrafinch (taeGut1), and anole (anoCar1)---a single amphibian (*Xenopus tropicalis*, xenTro2), and several fish. The fish include zebrafish (danRer6), *Fugu rubripes* (fr2), stickleback (gasAcu1), medaka (oryLat2), and *Tetraodon nigripes* (tetNig2). The PHAST program called tree_doctor was used to prune other taxa from the 46 species trees ([@msv344-B23]).

### Evolutionary Rates and Relationships

Rate matrices and branch lengths were obtained from <http://hgdownload.cse.ucsc.edu/goldenPath/hg19/multiz46way/> (last accessed January 3, 2016) and <http://genomewiki.ucsc.edu/index.php/Human/hg19/GRCh37_46-way_multiple_alignment> (last accessed January 3, 2016), respectively. Given their different rates of substitution, autosomes were analyzed separately from the X chromosome.

### Data Filters

We implemented several filters on the data to obtain orthologous elements that were well represented in the relevant taxa. First, we filtered out genomic regions overlapping human segmental duplications (genomicSuperDups) and repeat masked regions (rmsk) ([@msv344-B17]). Second, we required synteny between human and the chicken, fish (*F. rubripes*, *Danio rerio*), and/or frog (*X. tropicalis*). We used the netSynteny tracks from hg18 and then converted to hg19 coordinates using liftOver from the Kent library ([@msv344-B21]). Third, we required that each element have sequence covering at least 50% of bases from a marsupial, the monotreme, and at least one nonmammalian outgroup. This requirement focused our investigation on older elements that had a burst of change in the therian ancestor rather than on sequences that are found only in therians. We focused on elements that were important throughout vertebrate evolution but changed significantly in the therian ancestor. Furthermore, these older elements may have better functional annotation. We also required a minimum length of 45 nt and 30% coverage of nucleotides within the therian mammals.

### Identification of TCRs and TSARs

We used the PHAST program phastCons to identify elements that are conserved only among therian mammals ([@msv344-B23]). For running phastCons, we set rho at 0.5 for the therian subtree, which enforces a maximum rate of evolution of half the rate derived from 4-fold degenerate sites in coding regions. Stringent filtering followed by identifying conserved elements with phastCons resulted in 177,346 TCRs.

New code was developed in the PHAST program *phyloP* ([@msv344-B34]; [@msv344-B23]) to implement the internal branch test (‐‐branch option). Previously, it was possible to test a single terminal branch or an entire subtree. The null model is the same: It is a continuous time Markov model of nucleotide substitutions derived from neutral sequences. Here we used the REV model fit to 4-fold degenerate sites (separately for chromosome X and the autosomes). Each genomic region may be evolving faster or slower in all vertebrates; therefore all branch lengths of the phylogenetic tree from this model are then rescaled by a parameter to reflect the local expected substitution rate. This results in all branches of the tree being stretched or contracted by a single factor for each genomic region. The alternative model for the internal branch test is the null model with the therian ancestral branch scaled by a second parameter, which is constrained to be greater than 1 to reflect accelerated evolution in the ancestor of all therian mammals. Both models are fit to the multiple sequence alignment of each TCR by maximum likelihood. Thus, the internal branch test is a one-sided likelihood ratio test that compares the likelihood of data given the null model to the likelihood under a model that allows for acceleration along the therian ancestor branch. The *P* values from the internal branch test were adjusted for multiple comparisons using the false discovery rate ([@msv344-B5]).

### Simulations to Test Power and Specificity

Data simulated with acceleration on the therian ancestor branch can be used to test power and specificity of the internal branch test (supplementary fig. S1, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). The median rate that TCRs underwent substitution in our analysis was one-third the rate of 4-fold degenerate sites in protein-coding regions. Therefore, to simulate data with similar power to reject the null hypothesis (as in our empirical data), we rescaled all branch lengths in our null model tree using tree_doctor (--scale 0.33; supplementary fig. S1*A*, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). We simulated data using phyloBoot ([@msv344-B34]) with three different rates of substitution on the therian ancestor branch (supplementary fig. S1*B*, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online, branch in red). We used the null rescaled rate, 2× and 5× higher than the null rescaled rate. For each rate, we simulated 1,000 data sets at 3 sequence lengths: 150, 300, and 1500 bp. Median lengths of TCRs and TSARs are 177 and 359 bp, respectively. We used *phyloP* to test the simulated data sets for acceleration along the therian ancestor branch ([@msv344-B34]; [@msv344-B23]). The false positive rate was obtained from data simulated under the null model.

### Gene Annotation

Each phastCons element was annotated with genic information from the hg19 knownGene track in the UCSC database ([@msv344-B22]; [@msv344-B17]). Genic regions included UTRs, coding and noncoding exons, and introns.

### TSAR Distribution and Clusters

We tested whether TSARs occur closer or farther apart from each other compared with the TCRs from which they are drawn (supplementary fig. S2, [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online). In 1,000 data sets, we randomly chose 4,797 elements without replacement from the full set of TCRs. The median distance between TSARs (34,208 bp) is considerably shorter than the distance between the shuffled data sets (87,600 bp). We then defined TSAR clusters as any set of three or more TSARs where two neighboring TSARs are ≤50 kb apart. We used a binomial test conditioned on at least one TSAR being present in a cluster to test whether cluster regions are enriched for TSARs; the expected proportion of TSARs is based on the overall proportion of TSARs relative to phastCons elements. All clusters are enriched for TSARs at FDR \< 0.2 and the vast majority are highly enriched (FDR \< 0.05).

Laboratory Methods
------------------

In situ hybridizations were conducted using standard methods. In situ hybridization probes were obtained from Drs Stuart Orkin (Harvard University) and Marjo Salminen (University of Helsinki). Transgenic reporter constructs were made using a modified hsp68-LacZ construct engineered to harbor Gateway recombination sites. Either polymerase chain reaction--amplified fragments (primers in [supplementary table S6](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1), [Supplementary Material](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) online) or synthesized DNA fragments (Integrated DNA Technologies, Inc., Coralville, IA) from the mouse or chicken genome were cloned into pENTR1A and then shuttled into the modified lacZ reporter plasmid (Invivogen, San Diego, CA). Linearized DNA samples were sent to Cyagen Biosciences, Inc. (Santa Clara, CA) for pronuclear injection into the mouse embryo. We examined multiple independent transgenic embryos, each with a unique integration site. Only constructs with reproducible activity were considered. Some embryos were visualized by optical projection tomography using a Bioptonics, Inc. (Edinburgh, UK) device and analyzed with Volocity three-dimensional image analysis software (Perkin Elmer, Waltham, MA).

Supplementary Material
======================

[Supplementary figures S1--S7](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) and [tables S1--S6](http://mbe.oxfordjournals.org/lookup/suppl/doi:10.1093/molbev/msv344/-/DC1) are available at *Molecular Biology and Evolution* online (<http://www.mbe.oxfordjournals.org/>).
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